Right Turn: Time to stop the bleeding

Recently Revmedx, a pioneer in the biomaterial wound dressing field, made some waves with the commercialization of its product XStat^TM . XStat^TM received a lot of press because of its FDA approval for use against gunshot wounds and shrapnel-related injuries in the battlefield. It is used to help stop the bleeding and help sustain the injured individual’s life and need for proper medical care up to four hours from the occurrence of the junctional wound. Revmedx is working with the U.S. armed forces to develop groundbreaking medical products for use by combat medics, not unlike the work being conducted by the Armed Forces Institute of Regenerative Medicine, or AFIRM. There are other companies developing products for similar purposes, for example Suneris is working on Veti-Gel. Stacey Johnson featured Veti-Gel last year in a Right Turn post here.

Our regular feature, Right Turn, showcases the “lighter” side of stem cells and regenerative medicine. Every Friday, we will bring you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions that you are used to finding here, but they definitely won’t be blogs.

As always, we welcome your feedback and we also welcome suitable submissions. Be creative! Use the right (!) side of your brain. Make us laugh! Let’s see if we can make this new direction a positive one for all of us. Send your submission to info(at)ccrm.ca.

The following two tabs change content below.

• Bio
• Latest Posts

Roshan Yoganathan

Dr. Roshan Yoganathan is a subject matter expert in the area of biomaterials for cancer therapy and regenerative medicine applications with over 5 years of start-up experience in the area of combination products and class III medical devices. During his tenure at CCRM he was promoted from Development Scientist to Project Manager/Scientist and responsible for leading the Biomaterials and Devices platform. Roshan has also held several postdoctoral appointments such as Senior Postdoctoral researcher at the University of New South Wales (UNSW) (Sydney, Australia) and a Mitacs Elevate Postdoctoral Fellowship with Receptor Therapeutics and the University of Toronto (UofT). His scholarly route started with an undergraduate degree in Biomedical Engineering at UofT, then a Masters and PhD in Biomedical Engineering, both at UNSW. The focus of much of his work has been on the use of biomaterials for drug delivery and tissue engineering applications. In his spare time he enjoys playing sports, and is known to be an avid volleyball, badminton and basketball player.

Latest posts by Roshan Yoganathan (see all)

• Right Turn: Time to stop the bleeding - April 17, 2014
• Right Turn: Heart in a box – are we there yet? - March 7, 2014
• Biomimicry, bioadhesion and Dr. Jeffrey Karp: He’s a natural at what he does - February 18, 2014